chemo@home Offers Greater Convenience and Satisfaction to IBD Patients Receiving Infliximab and Vedolizumab
Many Inflammatory Bowel Disease (IBD) patients need ongoing treatment with immunotherapy medications given by infusion at regualr intervals. Traditionally these infusions have only been given in hospital. However, ground-breaking research presented at the Gastroenterological Society of Australia’s Annual meeting on the Gold Coast in August has highlighted the beneifts and safety of chemo@home for patients […]
